Skip to main navigation Skip to search Skip to main content

A 12-month, multi-center, randomized, open-label non-inferiority study of efficacy and safety comparing concentration-controlled Study Drug to Comparator Drug in de novo renal transplant recipient

Project: Research

Project Details

StatusFinished
Effective start/end date03/1/10 → 02/28/16

Funding

  • Novartis Pharmaceuticals Corporation: $126,806.73